Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rocket Pharmaceuticals (RCKT) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Rocket Pharmaceuticals (RCKT) over the last 10 years, with Q3 2025 value amounting to $4.9 million.

  • Rocket Pharmaceuticals' Prepaid Assets fell 1920.55% to $4.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.9 million, marking a year-over-year decrease of 1920.55%. This contributed to the annual value of $5.8 million for FY2024, which is 1585.1% up from last year.
  • As of Q3 2025, Rocket Pharmaceuticals' Prepaid Assets stood at $4.9 million, which was down 1920.55% from $5.7 million recorded in Q2 2025.
  • Rocket Pharmaceuticals' 5-year Prepaid Assets high stood at $14.8 million for Q1 2024, and its period low was $3.3 million during Q4 2021.
  • Its 5-year average for Prepaid Assets is $6.5 million, with a median of $5.7 million in 2025.
  • Per our database at Business Quant, Rocket Pharmaceuticals' Prepaid Assets soared by 17612.24% in 2024 and then plummeted by 5927.34% in 2025.
  • Over the past 5 years, Rocket Pharmaceuticals' Prepaid Assets (Quarter) stood at $3.3 million in 2021, then surged by 130.97% to $7.7 million in 2022, then tumbled by 34.16% to $5.0 million in 2023, then rose by 15.85% to $5.8 million in 2024, then fell by 15.82% to $4.9 million in 2025.
  • Its Prepaid Assets was $4.9 million in Q3 2025, compared to $5.7 million in Q2 2025 and $6.3 million in Q1 2025.